Nova Patents
EP1545652B1

Blood treatment equipment

Abstract

This record has no abstract on file.

EP1545652B1, drawing sheet 1
Sheet 1 of 28

Term

Term ended

Expired 4 September 2023, 3.1 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

42 claims: 7 independent, 35 dependent

  1. 1
    A blood treatment equipment, said equipment comprising at least a treatment unit including a semipermeable membrane separating the treatment unit in a first compartment for the circulation of blood and in a second compartment for the circulation of a treatment liquid, and a controller adapted to:- receive one or more entries of measured information measured during the course of a treatment procedure, - calculate from said measured information a value of at least a significant parameter indicative of the progress of an extracorporeal blood treatment carried out by the equipment, - compare said calculated significant parameter to at least a prescribed reference value for the same parameter, the prescribed reference value comprising the total dialysis dosage value KT p to be achieved at the end of the treatment, - generate at least one output control signal responsive to said comparison for automatically controlling one or more operations performed by the equipment, said controller determining, at time intervals during treatment o an instantaneous clearance K Ti or dialysance value D Ti measured at treatment time T i , o an effective total dialysis dosage KT Ti value which has been delivered at the elapsed treatment time T ti and o at least one among an estimated remaining treatment procedure time T tr and an estimated total treatment time T tot required for achieving said prescribed total dialysis dosage value KT p , wherein the controller is adapted to generate said output control signal responsive to said comparison for automatically controlling a fluid removal rate from said second comportment.
  2. 3
    Equipment according to claims 1 or 2, wherein said measured information is one chosen in the group comprising:- conductivity of the treatment liquid downstream the treatment unit;- concentration of a substance in the treatment liquid downstream the treatment unit.
  3. 4
    Equipment according to anyone of claims 1 to 5 wherein said controller is programmed for determining the estimated remaining treatment procedure time T tr as a function of said total dialysis dosage value KT p , the effective total dialysis dosage KT Ti achieved by time T i , and of the instantaneous clearance K Ti or dialysance value D Ti measured at treatment time T i .
  4. 5
    Equipment according to anyone of claims 1 to 3, wherein said controller is programmed for determining the estimated total treatment time T tot as a function of said total dialysis dosage value KT p , of the effective total dialysis dosage KT i achieved by time T i , and of the elapsed treatment time T i .
  5. 11
    Equipment according to anyone of claims from 1 to 10, wherein the controller is programmed for recalculating and updating at regular time intervals during treatment the estimated total treatment time T tot and/or the estimated remaining treatment time T tr , on the basis of the most recent value or values of instantaneous clearance K Ti or dialysance D Ti .
  6. 12
    Equipment according to anyone of claims from 1 to 10, wherein it is programmed for recalculating and updating at regular time Intervals during treatment the effective total dialysis dosage KT Ti value, which has been delivered at the elapsed effective treatment time T i .
  7. 26
    Equipment according to anyone of claims from 1 to 22, wherein the prescribed reference value comprises a patient blood conductivity or concentration target Cp end to be achieved, said controller being programmed for performing the following steps at each time Interval t i during at least a part of said treatment:o determining an interval target blood conductivity or concentration Cp i for the patient's blood, relating to a elapsed time Ti o modifying, if necessary, the conductivity or concentration for a substance C d of treatment liquid entering the second compartment to have the patient plasmatic conductivity reaching the interval target Cp i .